NCI-H2107 - MeSH

Warning: The NCBI web site requires JavaScript to function. more...

Search results

Items: 16

The following terms were not found in MeSH: H2107, NCI-H2107.

Select item 675388951.

NCI 83633 [Supplementary Concept]

a protein phosphatase 2C antagonist; structure in first source

Date introduced: March 4, 2009

Select item 674646582.

NCI 65828 [Supplementary Concept]

an angiogenin inhibitor and antineoplastic agent; structure in first source

Date introduced: August 31, 2002

Select item 680545473.

National Cancer Institute (U.S.)

Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.

Year introduced: 2008

Select item 680115534.

Pseudomyxoma Peritonei

A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).

Year introduced: 1987

Select item 675731235.

rhEDI-8t protein, human [Supplementary Concept]

from the NCI domain of collagen VIII; has antiangiogenic activity

Date introduced: June 28, 2012

Select item 675451326.

9-O-demethyltrigonostemone [Supplementary Concept]

from the roots of Strophioblachia fimbricalyx; showed cytotoxicity against NCI-H187, KB, and MCF7 cancer cells; structure in first source

Date introduced: November 27, 2009

Select item 675440367.

NCI-172033 [Supplementary Concept]

structure in first source

Date introduced: October 5, 2009

Select item 675079458.

AZ703 compound [Supplementary Concept]

AZ703-induced apoptosis in NCI-H1299 cells was enhanced by small interfering RNA-mediated depletion of cdk9, which caused reduced levels of Mcl-1 and XIAP, suggesting that cdk2, cdk1, and cdk9 represent a rational subset of family members for drug targeting

Date introduced: February 17, 2006

Select item 674983899.

spongidepsin [Supplementary Concept]

a 13-membered depsipeptide isolated from the Vanuatu marine sponge Spongia sp., has shown potent antitumor properties against a variety of NCI tumor cell lines

Date introduced: March 31, 2005

Select item 6746694710.

N-cyanomethyl-2-chloroisonicotinamide [Supplementary Concept]

structure in first source

Date introduced: October 23, 2002

Select item 6742577911.

3-methylglutamic acid [Supplementary Concept]

Date introduced: May 15, 2001

Select item 6710616512.

NCI PB 93-C-207 protocol [Supplementary Concept]

chemotherapy protocol consisting of above cpds used in treatment of non-Hodgkin's lymphomas

Date introduced: June 16, 1997

Select item 6707605413.

diethyl-n-butyltin(IV) trimethoxybenzoate [Supplementary Concept]

has in vitro cytotoxicity against 60 human NCI tumor cell lines

Date introduced: September 9, 1992

Select item 6707605314.

di-n-butyltin(IV) trimethoxybenzoate [Supplementary Concept]

has in vitro cytotoxicity against 60 human NCI tumor cell lines

Date introduced: September 9, 1992

Select item 6703448215.

CAV protocol [Supplementary Concept]

chemotherapy protocol consisting of cyclophosphamide, adriamycin, vincristine; CAV refers to first source; acronym ACV refers to second source; acronym ACO II was used in Klin Wochenschr 1982;60(16):829; acronym ACO was used in Onkology 1982;5(4):174; acronym DVC was used in Gan To Kagaku Ryoho 1984;11(4):888

Date introduced: June 18, 1982

Select item 6701319516.

sparfosic acid [Supplementary Concept]

inhibitor of aspartate transcarbamylase

Date introduced: January 1, 1976

MeSH

NLM Controlled Vocabulary

Send to:

Search results

Items: 16

Send to:

Supplemental Content